Protective Zika vaccines engineered to eliminate enhancement of dengue infection via immunodominance switch

Zika virus infection enhances future risk of severe dengue disease

(2020) Leah C. Katzelnick et al.   SCIENCE

Characterization of two engineered dimeric Zika virus envelope proteins as immunogen for neutralizing antibody selection and vaccine design

(2019) Chunpeng Yang et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

A protective Zika virus E-dimer-based subunit vaccine engineered to abrogate antibody-dependent enhancement of dengue infection

(2019) Jose Luis Slon-Campos et al.   NATURE IMMUNOLOGY

Zika virus vaccines

(2018) Peter Abbink et al.   NATURE REVIEWS MICROBIOLOGY

Effect of Dengue Serostatus on Dengue Vaccine Safety and Efficacy

(2018) Saranya Sridhar et al.   NEW ENGLAND JOURNAL OF MEDICINE

Maternally Acquired Zika Antibodies Enhance Dengue Disease Severity in Mice

(2018) Angela M. Fowler et al.   Cell Host & Microbe

An update on Zika virus infection

(2017) David Baud et al.   LANCET

Antibody-dependent enhancement of severe dengue disease in humans

(2017) Leah C. Katzelnick et al.   SCIENCE

Durability and correlates of vaccine protection against Zika virus in rhesus monkeys

(2017) Peter Abbink et al.   Science Translational Medicine

Dengvaxia sensitizes seronegatives to vaccine enhanced disease regardless of age

(2017) Scott B. Halstead   VACCINE

Covalently linked dengue virus envelope glycoprotein dimers reduce exposure of the immunodominant fusion loop epitope

(2017) Alexander Rouvinski et al.   Nature Communications

Prior Exposure to Zika Virus Significantly Enhances Peak Dengue-2 Viremia in Rhesus Macaques

(2017) Jeffy George et al.   Scientific Reports

The development of therapeutic antibodies against dengue virus

(2016) Guntur Fibriansah et al.   ANTIVIRAL RESEARCH

Structural Basis of Zika Virus-Specific Antibody Protection

(2016) Haiyan Zhao et al.   CELL

Zika Virus Causes Testis Damage and Leads to Male Infertility in Mice

(2016) Wenqiang Ma et al.   CELL

Structures of the Zika Virus Envelope Protein and Its Complex with a Flavivirus Broadly Protective Antibody

(2016) Lianpan Dai et al.   Cell Host & Microbe

A Mouse Model of Zika Virus Pathogenesis

(2016) Helen M. Lazear et al.   Cell Host & Microbe

Guillain-Barré Syndrome outbreak associated with Zika virus infection in French Polynesia: a case-control study

(2016) Van-Mai Cao-Lormeau et al.   LANCET

Structural basis of potent Zika–dengue virus antibody cross-neutralization

(2016) Giovanna Barba-Spaeth et al.   NATURE

Vaccine protection against Zika virus from Brazil

(2016) Rafael A. Larocca et al.   NATURE

Zika virus infection damages the testes in mice

(2016) Jennifer Govero et al.   NATURE

Miscarriage Associated with Zika Virus Infection

(2016) Annemiek A. van der Eijk et al.   NEW ENGLAND JOURNAL OF MEDICINE

Zika Virus Infection in Pregnant Women in Rio de Janeiro

(2016) Patrícia Brasil et al.   NEW ENGLAND JOURNAL OF MEDICINE

Zika Virus and Birth Defects — Reviewing the Evidence for Causality

(2016) Sonja A. Rasmussen et al.   NEW ENGLAND JOURNAL OF MEDICINE

Specificity, cross-reactivity, and function of antibodies elicited by Zika virus infection

(2016) K. Stettler et al.   SCIENCE

Molecular determinants of human neutralizing antibodies isolated from a patient infected with Zika virus

(2016) Q. Wang et al.   Science Translational Medicine

Description of 13 Infants Born During October 2015–January 2016 With Congenital Zika Virus Infection Without Microcephaly at Birth — Brazil

(2016) Vanessa van der Linden et al.   MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT

Hybrid flagellin as a T cell independent vaccine scaffold

(2015) Kaila M. Bennett et al.   BMC BIOTECHNOLOGY

Dengue Virus prM-Specific Human Monoclonal Antibodies with Virus Replication-Enhancing Properties Recognize a Single Immunodominant Antigenic Site

(2015) Scott A. Smith et al.   JOURNAL OF VIROLOGY

Recognition determinants of broadly neutralizing human antibodies against dengue viruses

(2015) Alexander Rouvinski et al.   NATURE

A new class of highly potent, broadly neutralizing antibodies isolated from viremic patients infected with dengue virus

(2014) Wanwisa Dejnirattisai et al.   NATURE IMMUNOLOGY

High-Avidity and Potently Neutralizing Cross-Reactive Human Monoclonal Antibodies Derived from Secondary Dengue Virus Infection

(2013) Wen-Yang Tsai et al.   JOURNAL OF VIROLOGY

IgBLAST: an immunoglobulin variable domain sequence analysis tool

(2013) Jian Ye et al.   NUCLEIC ACIDS RESEARCH

Sculpting humoral immunity through dengue vaccination to enhance protective immunity

(2012) Wayne D. Crill et al.   Frontiers in Immunology

A Broadly Flavivirus Cross-Neutralizing Monoclonal Antibody that Recognizes a Novel Epitope within the Fusion Loop of E Protein

(2011) Yong-Qiang Deng et al.   PLoS One

The Human Immune Response to Dengue Virus Is Dominated by Highly Cross-Reactive Antibodies Endowed with Neutralizing and Enhancing Activity

(2010) Martina Beltramello et al.   Cell Host & Microbe

Search for New Particles in Two-Jet Final States in 7 TeV Proton-Proton Collisions with the ATLAS Detector at the LHC

(2010) G. Aad et al.   PHYSICAL REVIEW LETTERS

Cross-Reacting Antibodies Enhance Dengue Virus Infection in Humans

(2010) W. Dejnirattisai et al.   SCIENCE

MolProbity: all-atom structure validation for macromolecular crystallography

(2009) Vincent B. Chen et al.   ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY

Structural basis for the preferential recognition of immature flaviviruses by a fusion-loop antibody

(2009) Mickaël V Cherrier et al.   EMBO JOURNAL